Proto Script Pharmaceutical (Proto Script Pharmaceutical) Earnings Yield (Joel Greenblatt) % : -36.50% (As of Sep. 2017)

Proto Script Pharmaceutical Earnings Yield (Joel Greenblatt) % Chart

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
Earnings Yield (Joel Greenblatt) %	Get a 7-Day Free Trial															-0.10	-0.15	-18.28	-31.15	-36.50

Competitive Comparison of Proto Script Pharmaceutical's Earnings Yield (Joel Greenblatt) %

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proto Script Pharmaceutical's Earnings Yield (Joel Greenblatt) % Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Earnings Yield (Joel Greenblatt) % falls into.

Proto Script Pharmaceutical Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Proto Script Pharmaceuticals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in May. 2016 is calculated as

Proto Script Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.85 Mil.

Proto Script Pharmaceutical  (OTCPK:PSCR) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.

Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.

Proto Script Pharmaceutical Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description